Tilisolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QUF41MF56G, chemically known as 1(2h)-isoquinolinone, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-2-methyl- but generally known as tilisolol, which bears US NIH Compound Identifier 5474. European Medicines Agency schedules Tilisolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11053MIG. The term TILISOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). TILISOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tilisolol under HS 29337900 and SITC 51561. As of Q4 2014, TILISOLOL remains the US FDA Preferred Term for this commodity. Tilisolol bears US NLM identifiers UMLS ID C0076678 and NCI Concept Code C76560. SMILES: O(CC(O)CNC(C)(C)C)C1C2C(C(=O)N(C1)C)CCCC2.